Create your own
Lesson illustration

Clinically and Environmentally Important Members of the Enterobacter cloacae Complex

Welcome. This module builds a precise vocabulary for discussing Enterobacter before we turn to resistance mechanisms, carbapenemases, plasmids, and genomic investigation. The name Enterobacter cloacae is often used loosely in clinical reports, but it can conceal a set of closely related organisms with different distributions, resistance patterns, and epidemiological significance.

In this lesson, you will learn which organisms are usually included in the Enterobacter cloacae complex (ECC), which members matter most in hospitals and environmental surveillance, and why a report of “ECC” is useful but less specific than a genome-supported species assignment.


The Enterobacter cloacae complex: a related group, not one uniform organism

The ECC is a cluster of closely related Enterobacter species. They can look very similar in routine laboratory tests, yet their genomes reveal distinct lineages. Historically, many isolates that would now be assigned to several ECC members were simply called E. cloacae. That history explains why older literature may overstate the role of E. cloacae sensu stricto while under-recognizing E. hormaechei, E. kobei, and others.

The word complex is important. It signals that:

  • the organisms are close enough genetically and phenotypically to be difficult to separate in routine work;
  • they share broad ecological capacities, including survival in water, soil, plants, animals, and healthcare settings;
  • they are not interchangeable in clinical epidemiology or antimicrobial-resistance surveillance;
  • the list of members and the preferred species or subspecies names can change as genome-based taxonomy develops.
A phylogenetic tree based on partial \(hsp60\) gene sequences shows clusters corresponding to ECC species and several lineages labeled as* Enterobacter hormaechei *subspecies. Branching illustrates relatedness within the complex; it does not mean that every branch is equally common, virulent, or resistant.

A phylogenetic tree such as this one is a map of sequence similarity, not a clinical ranking. A lineage placed close to another lineage is genetically related at the gene being compared; it is not automatically more dangerous, more transmissible, or more likely to carry a carbapenemase.

Species identification, antibiotic resistance, and virulence in Enterobacter cloacae complex clinical isolates from South Korea

Read the Introduction of this clinical ECC study. It gives a practical starting membership list for the complex and explains why conventional identification often reports an isolate only as ECC.

In the Introduction, read from the sentence beginning the ECC membership overview. Focus on the distinction between the named core species, more recently described ECC-associated species, and the limitations of phenotype-based identification and 16S rRNA sequencing.


The members you should recognize

A useful working approach is to separate the ECC into three categories: frequent healthcare-associated members, established but less commonly recognized members, and newer or relatively infrequent members that still matter in surveillance.

ECC memberWhy it matters clinicallyWhy it matters environmentally or epidemiologically
Enterobacter hormaecheiOften the dominant ECC species in healthcare collections; strongly associated with multidrug resistance and globally disseminated high-risk lineages.Can persist in healthcare-associated environments and move through patient, equipment, wastewater, and plumbing-associated networks.
Enterobacter kobeiRecovered from human infections and may carry clinically important acquired resistance genes.A reminder that non-hormaechei ECC isolates may be clinically relevant rather than incidental.
Enterobacter ludwigiiDocumented among clinical ECC isolates; can show different susceptibility and virulence-associated phenotypes from other members.Part of the genetically close pool that can be misidentified as E. cloacae by routine methods.
Enterobacter asburiaeCauses or is associated with human infection, particularly in vulnerable hosts, but is often less emphasized than E. hormaechei.Found in diverse nonclinical habitats, including plant-associated settings, soil, and water.
Enterobacter cloacae sensu strictoThe historical name most often applied to the complex; genuine E. cloacae remains clinically relevant.Has representatives from plant, soil, and human-associated niches. Its ecological breadth helped create the older “one species” impression.
Enterobacter roggenkampiiIncreasingly recognized among clinical isolates when higher-resolution methods are used.Illustrates how genomic identification can uncover lineages previously hidden inside the ECC label.
Enterobacter bugandensisAn emerging clinically important species reported from human infection and increasingly considered in genomic surveillance.Its recognition shows why databases and identification schemes must be updated as new ECC members are described.
Enterobacter chengduensisLess frequent in many collections but has been recovered from clinical material, including isolates with reduced carbapenem susceptibility.Important not to dismiss as irrelevant merely because it is uncommon.
Enterobacter mori and Enterobacter nimipressuralisUsually less prominent in hospital reports than E. hormaechei, but relevant to the breadth of the complex and occasional clinical detection.Their plant and environmental associations reinforce that ECC is not a hospital-only group.

E. hormaechei: the species to prioritize in carbapenemase surveillance

If a hospital reports large numbers of “E. cloacae complex,” E. hormaechei is frequently the species that deserves special attention. It is widely recognized as an important healthcare-associated ECC organism and can acquire mobile carbapenemase genes such as those encoding KPC, NDM, VIM, or IMP enzymes.

However, keep two statements separate:

  1. An isolate is E. hormaechei. This is a taxonomic claim.
  2. An isolate produces a carbapenemase. This is a resistance-mechanism claim.

Neither statement guarantees the other. Many E. hormaechei isolates do not carry carbapenemases; conversely, carbapenemase genes can occur in other ECC species because resistance genes can move on plasmids, transposons, and integrons.

The South Korean clinical study provides a useful example of why species-level resolution matters. Among 183 ECC clinical isolates, E. hormaechei accounted for 47.0%, followed by E. kobei, E. asburiae, E. ludwigii, and E. roggenkampii. Those proportions are not a universal global distribution. They reflect one place, time, sampling strategy, patient population, and identification method. But they demonstrate that “ECC” in a hospital collection is often a mixture of species rather than a population of true E. cloacae alone.

Within that study’s identification framework, E. hormaechei was further divided into lineages labeled subsp. xiangfangensis, subsp. steigerwaltii, subsp. hormaechei, and subsp. hoffmannii. You will encounter these names in papers and genome databases. The exact rank and naming of these lineages is an area of active taxonomic revision, which is why recording the method and database used for assignment is essential.

Species identification, antibiotic resistance, and virulence in Enterobacter cloacae complex clinical isolates from South Korea

Continue with the same study to see a concrete example of species and subspecies distribution in clinical isolates, followed by a discussion of why those distinctions affect surveillance.

First, in Results, read the subsection “Species identification,” including Table 1 and the Figure 1 legend. Begin at the identification basis, then continue through the paragraph describing the four reported E. hormaechei subspecies. Note that the table is a local clinical dataset, not a global frequency table. Then read the opening paragraphs of Discussion, especially the discussion of phenotypic identification, hsp60-based assignment, and changing names. Finish by reading the paragraph beginning “In the present study, diverse species of ECC were identified in patients,” through the paragraph that identifies E. hormaechei as predominant. Focus on why a label of “ECC” may hide species-level diversity.


Ecological breadth: from plants and soil to plumbing and patients

ECC organisms are opportunists. This means disease usually depends on a combination of organism traits, route of entry, host vulnerability, medical devices, antimicrobial exposure, and local ecology. It does not mean that every ECC isolate from water, a plant, or a patient has the same capacity to cause invasive infection.

Members of the complex are found across several connected ecological settings:

  • Plants and the rhizosphere: Some strains colonize plant interiors as endophytes, interact with roots, or promote plant growth. Others have been associated with plant disease.
  • Soil, surface water, and wastewater: These environments supply nutrients, moisture, microbial competitors, metals, disinfectant residues, and opportunities for gene exchange.
  • Human and animal-associated sites: Colonization can occur without disease, particularly in the gastrointestinal tract or on damp surfaces.
  • Healthcare environments: Sinks, drains, traps, faucets, wastewater plumbing, moist cleaning equipment, and contaminated surfaces can all support or receive ECC populations.
  • Patients: ECC may be recovered from urine, respiratory specimens, wounds, blood, or device-associated infections, especially in critically ill or immunocompromised people.

The same broad ecological ability that allows survival outside the patient can complicate hospital investigations. Suppose an ECC isolate is found in a sink drain and another is recovered from a patient. The species name alone cannot establish transmission. Both might represent unrelated strains of the same species, repeated introductions from different sources, or a genuinely linked strain. Later in the course, whole-genome comparisons and plasmid analysis will provide the resolution needed to investigate that question.

Comparative Genome Analysis of Enterobacter cloacae - PMC

This older comparative-genomics paper is useful for seeing the ecological range historically assigned to E. cloacae. Read it as evidence of ecological diversity, while remembering that modern genome-based taxonomy may refine the species labels used in older studies.

In the Introduction, read the first three paragraphs, which move from plant, soil, and endophytic isolates to human opportunistic infection. Then read the hospital context. Focus on the central lesson: origin from a plant, soil, or water setting does not prevent a lineage from becoming clinically relevant under the right conditions.

Environment is not the same as contamination

In environmental microbiology, it is tempting to call any ECC recovered from a sink, drain, or water sample a “contaminant.” That word is often too vague. An isolate may be:

  • a resident population that has persisted and grown in a drain biofilm;
  • a recent introduction from handwashing waste, patient fluids, or cleaning activity;
  • a transient survivor that will disappear without establishing;
  • a laboratory contaminant, introduced during sampling or culture;
  • or part of a chain of transmission involving patients, plumbing, or staff-mediated contact.

Species identification is one useful layer of interpretation, but it cannot resolve these possibilities alone. For example, finding E. hormaechei in both clinical and environmental samples justifies closer investigation; it does not prove a shared source. The evidence becomes stronger only when the strains are shown to be closely related by appropriately controlled genomic analysis and when timing, locations, and plausible exposure routes agree.


Species differences: useful signals, not deterministic rules

Species-level identification can reveal meaningful patterns, but it must never be treated as a shortcut for predicting an individual isolate’s phenotype.

In the clinical study you read, E. hormaechei, E. kobei, and E. ludwigii generally showed greater survival in normal human serum than E. asburiae and E. roggenkampii. Serum survival is one experimental measure associated with the ability to withstand part of innate host defense. It is not a complete definition of virulence, and the isolates within each species varied substantially.

Similarly, the study found differing resistance frequencies among ECC species. Such observations are useful for surveillance hypotheses, but they do not allow a safe prediction for a single isolate. Resistance depends on its particular collection of chromosomal mutations, intrinsic mechanisms, acquired genes, plasmids, gene expression, and antibiotic exposure history.

Use this interpretation hierarchy:

StatementStrength
“This isolate belongs to E. hormaechei.”A taxonomic claim, whose confidence depends on the identification method and reference database.
E. hormaechei is often important in hospital ECC collections.”A useful epidemiological generalization, but location- and time-dependent.
“This E. hormaechei isolate is carbapenem resistant.”A phenotype claim that requires susceptibility testing.
“This isolate produces a carbapenemase.”A mechanism claim requiring a validated phenotypic and/or molecular basis.
“This sink isolate caused this patient infection.”A transmission claim requiring integrated epidemiological and high-resolution microbiological evidence.

This hierarchy will protect you from a common error: treating a species name as if it answers every clinical, resistance, and outbreak question.


A practical reporting mindset

When reading a paper or interpreting laboratory data, make the resolution of the identification explicit.

A cautious statement might be:

“An Enterobacter cloacae complex isolate was recovered. Routine identification did not resolve species; therefore, it should not be reported as E. cloacae sensu stricto.”

A stronger statement, if supported by a suitable genomic method, might be:

“The isolate was assigned to Enterobacter hormaechei using genome-based comparison against curated references.”

For the carbapenemase-focused parts of this course, the most informative isolate description will eventually combine:

  1. Taxon: ECC, species, and where defensible, subspecies.
  2. Phenotype: carbapenem MICs and interpretation under the applicable breakpoint standard.
  3. Mechanism: whether a carbapenemase gene or activity is detected.
  4. Gene context: chromosomal location, plasmid carriage, and surrounding mobile elements.
  5. Epidemiological context: patient, ward, date, sample source, and environmental links.

At this stage, the essential point is simpler: ECC is diverse. E. hormaechei merits particularly close clinical attention, but E. kobei, E. ludwigii, E. asburiae, E. cloacae sensu stricto, E. roggenkampii, E. bugandensis, E. chengduensis, and less frequent members can all matter depending on the setting.


The key takeaways are that the ECC contains multiple closely related species; E. hormaechei is often prominent in healthcare-associated collections; and environmental occurrence, clinical relevance, resistance, and transmission are separate questions that must be investigated at the appropriate level of evidence. Older reports using “E. cloacae” may group together several organisms now recognized as distinct.

Next, we will examine why ECC species and subspecies assignments change as genomic taxonomy develops, and how to read changing names without losing track of the organism being described.

Can't find a good explanation? Sign up and we'll make it for you

Sign up